The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Platinum based Cancer Drug Market Research Report 2018

Global Platinum based Cancer Drug Market Research Report 2018

Publishing Date : Jul, 2018

License Type :
 

Report Code : 1209528

No of Pages : 172

Synopsis
This report studies the Platinum based Cancer Drug market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Platinum based Cancer Drug market by product type and applications/end industries.

In the last several years, global market of platinum based cancer drug developed smoothly, with an average growth rate of 4.29%. In 2017, global revenue of platinum based cancer drug is nearly 1285 M USD; the actual sales are about 27572 K units.


The major players in global Platinum based Cancer Drug market include

  • Sanofi
  • Hengrui Medicine
  • ASK Pharma
  • Yi Bai Pharmaceutical
  • Qilu Pharmaceutical
  • Teva
  • Pfizer
  • Dr Reddy's Laboratories
  • Mylan
  • Sun Pharma
  • Novartis
  • Debiopharm
  • Accord Healthcare
  • SK Chemicals

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth rate of Platinum based Cancer Drug in these regions, from 2013 to 2025 (forecast), covering

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

On the basis of product, the Platinum based Cancer Drug market is primarily split into

  • Cisplatin
  • Oxaliplatin
  • Carboplatin
  • Other

On the basis on the end users/applications, this report covers

  • Colorectal Cancer
  • Ovarian Cancer
  • Lung Cancer
  • Other
Index

Table of Contents

1 Platinum based Cancer Drug Market Overview 1
1.1 Platinum based Cancer Drug Product Overview 1
1.2 Platinum based Cancer Drug Segment by Types (Product Category) 1
1.2.1 Global Platinum based Cancer Drug Sales by Types 1
1.2.2 Global Platinum based Cancer Drug Sales Market Share by Types in 2017 2
1.2.3 Cisplatin 3
1.2.4 Oxaliplatin 3
1.2.5 Carboplatin 4
1.3 Global Platinum based Cancer Drug Segment by Applications 4
1.3.1 Global Platinum based Cancer Drug Sales Comparison by Applications 4
1.3.2 Colorectal Cancer 5
1.3.3 Ovarian Cancer 6
1.3.4 Lung Cancer 6
1.4 Global Platinum based Cancer Drug Market by Regions (2013-2025) 7
1.4.1 Global Platinum based Cancer Drug Market Size Comparison by Regions (2013-2025) 7
1.4.2 North America Platinum based Cancer Drug Status and Prospect (2013-2025) 8
1.4.3 Europe Platinum based Cancer Drug Status and Prospect (2013-2025) 9
1.4.4 Asia-Pacific Platinum based Cancer Drug Status and Prospect (2013-2025) 10
1.4.5 South America Platinum based Cancer Drug Status and Prospect (2013-2025) 11
1.4.6 Middle East & Africa Platinum based Cancer Drug Status and Prospect (2013-2025) 12
1.5 Global Platinum based Cancer Drug Market Size (2013-2025) 13
1.5.1 Global Platinum based Cancer Drug Revenue Status and Outlook (2013-2025) 13
1.5.2 Global Platinum based Cancer Drug Sales Status and Outlook (2013-2025) 14
2 Global Platinum based Cancer Drug Market Competition by Manufacturers 15
2.1 Global Platinum based Cancer Drug Sales and Share by Manufacturers (2017-2018) 15
2.2 Global Platinum based Cancer Drug Revenue and Share by Manufacturers (2017-2018) 17
2.3 Global Platinum based Cancer Drug Average Price by Manufacturers (2017-2018) 20
2.4 Manufacturers Platinum based Cancer Drug Headquarters and Established 22
2.5 Platinum based Cancer Drug Market Competitive Situation and Trends 23
2.5.1 Platinum based Cancer Drug Market Concentration Rate 23
2.5.2 Platinum based Cancer Drug Market Share of Top 3 and Top 5 Manufacturers 24
2.5.3 Mergers & Acquisitions, Expansion 25
3 Global Platinum based Cancer Drug Sales by Regions (2013-2018) 30
3.1 Global Platinum based Cancer Drug Sales and Market Share by Regions (2013-2018) 30
3.2 Global Platinum based Cancer Drug Revenue and Market Share by Regions (2013-2018) 32
3.3 Global Platinum based Cancer Drug Sales, Revenue, Price (2013-2018) 35
3.4 North America Platinum based Cancer Drug Sales (2013-2018) 36
3.4.1 North America Platinum based Cancer Drug Sales and Growth Rate (2013-2018) 36
3.4.2 North America Platinum based Cancer Drug Sales, Revenue, Price (2013-2018) 36
3.5 Europe Platinum based Cancer Drug Sales (2013-2018) 37
3.5.1 Europe Platinum based Cancer Drug Sales and Growth Rate (2013-2018) 37
3.5.2 Europe Platinum based Cancer Drug Sales, Revenue, Price (2013-2018) 38
3.6 Asia-Pacific Platinum based Cancer Drug Sales (2013-2018) 39
3.6.1 Asia-Pacific Platinum based Cancer Drug Sales and Growth Rate (2013-2018) 39
3.6.2 Asia-Pacific Platinum based Cancer Drug Sales, Revenue, Price (2013-2018) 39
3.7 South America Platinum based Cancer Drug Sales (2013-2018) 40
3.7.1 South America Platinum based Cancer Drug Sales and Growth Rate (2013-2018) 40
3.7.2 South America Platinum based Cancer Drug Sales, Revenue, Price (2013-2018) 41
3.8 Middle East & Africa Platinum based Cancer Drug Sales (2013-2018) 42
3.8.1 Middle East & Africa Platinum based Cancer Drug Sales and Growth Rate (2013-2018) 42
3.8.2 Middle East & Africa Platinum based Cancer Drug Sales, Revenue, Price (2013-2018) 43
4 Global Platinum based Cancer Drug Sales, Revenue (Value), Price Trend by Types 44
4.1 Global Platinum based Cancer Drug Sales and Market Share by Types (2013-2018) 44
4.2 Global Platinum based Cancer Drug Revenue and Market Share by Types (2013-2018) 46
4.3 Global Platinum based Cancer Drug Price by Types (2013-2018) 48
4.4 Global Platinum based Cancer Drug Sales Growth Rate by Types (2013-2018) 48
5 Global Platinum based Cancer Drug Market Analysis by Applications 49
5.1 Global Platinum based Cancer Drug Sales and Market Share by Applications (2013-2018) 49
5.2 Global Platinum based Cancer Drug Sales Growth Rate by Applications (2013-2018) 51
6 Analysis of Platinum based Cancer Drug Industry Key Manufacturers 52
6.1 Sanofi 52
6.1.1 Company Profile 52
6.1.2 Product Information 53
6.1.3 Sales, Price, Cost, Gross, and Revenue 54
6.2 Hengrui Medicine 54
6.2.1 Company Profile 54
6.2.2 Product Information 55
6.2.3 Sales, Price, Cost, Gross, and Revenue 56
6.3 ASK Pharma 56
6.3.1 Company Profile 56
6.3.2 Product Information 57
6.3.3 Sales, Price, Cost, Gross, and Revenue 57
6.4 Yi Bai Pharmaceutical 58
6.4.1 Company Profile 58
6.4.2 Product Information 59
6.4.3 Sales, Price, Cost, Gross, and Revenue 59
6.5 Qilu Pharmaceutical 60
6.5.1 Company Profile 60
6.5.2 Product Information 61
6.5.3 Sales, Price, Cost, Gross, and Revenue 61
6.6 Teva 61
6.6.1 Company Profile 61
6.6.2 Product Information 63
6.6.3 Sales, Price, Cost, Gross, and Revenue 63
6.7 Pfizer 64
6.7.1 Company Profile 64
6.7.2 Product Information 65
6.7.3 Sales, Price, Cost, Gross, and Revenue 65
6.8 Dr Reddy’s Laboratories 66
6.8.1 Company Profile 66
6.8.2 Product Information 67
6.8.3 Sales, Price, Cost, Gross, and Revenue 67
6.9 Mylan 68
6.9.1 Company Profile 68
6.9.2 Product Information 69
6.9.3 Sales, Price, Cost, Gross, and Revenue 69
6.10 Sun Pharma 70
6.10.1 Company Profile 70
6.10.2 Product Information 71
6.10.3 Sales, Price, Cost, Gross, and Revenue 71
6.11 Novartis 72
6.11.1 Company Profile 72
6.11.2 Product Information 73
6.11.3 Sales, Price, Cost, Gross, and Revenue 73
6.12 Debiopharm 74
6.12.1 Company Profile 74
6.12.2 Product Information 75
6.12.3 Sales, Price, Cost, Gross, and Revenue 75
6.13 Accord Healthcare 76
6.13.1 Company Profile 76
6.13.2 Product Information 77
6.13.3 Sales, Price, Cost, Gross, and Revenue 77
6.14 SK Chemicals 78
6.14.1 Company Profile 78
6.14.2 Product Information 79
6.14.3 Sales, Price, Cost, Gross, and Revenue 79
7 Platinum based Cancer Drug Manufacturing Cost Analysis 80
7.1 Platinum based Cancer Drug R&D Cost Analysis 80
7.1.1Clinical Phase Costs 81
7.1.2 Capitalized Costs 82
7.2 Proportion of Manufacturing Cost Structure 83
7.2.1 Raw Materials 83
7.2.2 Labor Cost 84
7.2.2.1 USA Labor Cost Analysis 84
7.2.2.2 Europe Labor Costs Analysis 85
7.2.2.3 Asia Labor Costs Analysis 87
7.2.3 Other Costs Analysis 88
7.2.3.1 USA Cost of Electricity Analysis 88
7.2.3.2 USA Water Cost Analysis 88
7.2.3.3 Europe Cost of Electricity Analysis 89
7.2.3.4 Europe Water Cost Analysis 90
7.2.3.5 China Cost of Electricity Analysis 91
7.2.3.6 China Water Cost Analysis 92
7.3 Manufacturing Process Analysis of Platinum based Cancer Drug 93
8 Industrial Chain, Sourcing Strategy and Downstream Buyers 94
8.1 Platinum based Cancer Drug Industrial Chain Analysis 94
8.2 Upstream Raw Materials Sourcing 95
8.3 Downstream Buyers 95
9 Marketing Strategy Analysis, Distributors/Traders 98
9.1 Marketing Channel 98
9.1.1 Direct Marketing 100
9.1.2 Indirect Marketing 100
9.1.3 Marketing Channel Development Trend 101
9.2 Market Positioning 102
9.2.1 Pricing Strategy 102
9.2.2 Brand Strategy 103
9.3 Distributors/Traders List 104
10 Market Effect Factors Analysis 107
10.1 Technology Progress/Risk 107
10.1.1 New Active Substance Launches 2011-2015 by Indication 107
10.1.2 Rapid Uptake of New Immune-oncology Drugs Reflects Their Remarkable Clinical Profile and Expansion of Indications 108
10.1.3 Technology Progress in Related Industry 109
10.2 Cancer Patients Analysis 112
10.2.1 Key Facts 112
10.2.2 Cancer Incidence and Mortality Analysis 114
10.3 Economic/Political Environmental Change 115
11 Global Platinum based Cancer Drug Market Forecast (2019-2025) 124
11.1 Global Platinum based Cancer Drug Sales, Revenue Forecast (2019-2025) 124
11.1.1 Global Platinum based Cancer Drug Sales and Growth Rate Forecast (2019-2025) 124
11.1.2 Global Platinum based Cancer Drug Revenue and Growth Rate Forecast (2019-2025) 125
11.1.3 Global Platinum based Cancer Drug Price and Trend Forecast (2019-2025) 126
11.2 Global Platinum based Cancer Drug Sales Forecast by Regions (2019-2025) 126
11.2.1 North America Platinum based Cancer Drug Sales and Revenue Forecast (2019-2025) 128
11.2.2 Europe Platinum based Cancer Drug Sales and Revenue Forecast (2019-2025) 130
11.2.3 Asia-Pacific Platinum based Cancer Drug Sales and Revenue Forecast (2019-2025) 132
11.2.4 South America Platinum based Cancer Drug Sales and Revenue Forecast (2019-2025) 134
11.2.5 Middle East & Africa Platinum based Cancer Drug Sales and Revenue Forecast (2019-2025) 136
11.3 Global Platinum based Cancer Drug Revenue Forecast by Regions (2019-2025) 137
11.3.1 North America Platinum based Cancer Drug Revenue Forecast (2019-2025) 139
11.3.2 Europe Platinum based Cancer Drug Revenue Forecast (2019-2025) 140
11.3.3 Asia-Pacific Platinum based Cancer Drug Revenue Forecast (2019-2025) 141
11.3.4 South America Platinum based Cancer Drug Revenue Forecast (2019-2025) 142
11.3.5 Middle East & Africa Platinum based Cancer Drug Revenue Forecast (2019-2025) 143
11.4 Global Platinum based Cancer Drug Sales, Revenue and Price Forecast by Types (2019-2025) 143
11.4.1 Global Platinum based Cancer Drug Sales Forecast by Types (2019-2025) 143
11.4.2 Global Platinum based Cancer Drug Revenue Forecast by Types (2019-2025) 145
11.4.3 Global Platinum based Cancer Drug Price Forecast by Types (2019-2025) 147
11.5 Global Platinum based Cancer Drug Sales Forecast by Application (2019-2025) 148
12 Research Findings and Conclusion 150
13 Methodology and Data Source 151
13.1 Methodology/Research Approach 151
13.1.1 Research Programs/Design 151
13.1.2 Market Size Estimation 152
1.3 Market Breakdown and Data Triangulation 153
13.2 Data Source 154
13.2.1 Secondary Sources 154
13.2.2 Primary Sources 155
13.3 Author List 156
13.4 Disclaimer 157

List of Tables

List of Tables and Figures

Figure Product Picture of Platinum based Cancer Drug 1
Table Global Platinum based Cancer Drug Sales (K Unit) Comparison by Types (2013-2025) 1
Figure Global Platinum based Cancer Drug Sales Market Share by Types in 2017 2
Figure Product Picture of Cisplatin 3
Figure Product Picture of Oxaliplatin 3
Figure Product Picture of Carboplatin 4
Table Global Platinum based Cancer Drug Sales (K Unit) Comparison by Applications (2013-2025) 4
Figure Global Platinum based Cancer Drug Sales Market Share by Applications in 2017 5
Figure Colorectal Cancer Examples 5
Figure Ovarian Cancer Examples 6
Figure Lung Cancer Examples 6
Table Global Platinum based Cancer Drug Market Size (M USD) Comparison by Regions (2013-2025) 7
Figure North America Platinum based Cancer Drug Revenue (M USD) and Growth Rate (2013-2025) 8
Figure Europe Platinum based Cancer Drug Revenue (M USD) and Growth Rate (2013-2025) 9
Figure Asia-Pacific Platinum based Cancer Drug Revenue (M USD) and Growth Rate (2013-2025) 10
Figure South America Platinum based Cancer Drug Revenue (M USD) and Growth Rate (2013-2025) 11
Figure Middle East & Africa Platinum based Cancer Drug Revenue (M USD) and Growth Rate (2013-2025) 12
Figure Global Platinum based Cancer Drug Revenue (M USD) Status and Outlook (2013-2025) 13
Figure Global Platinum based Cancer Drug Sales (K Unit) Status and Outlook (2013-2025) 14
Table Global Platinum based Cancer Drug Sales (K Unit) of Key Manufacturers (2017-2018) 15
Table Global Platinum based Cancer Drug Sales Market Share by Manufacturers (2017-2018) 15
Figure 2017 Platinum based Cancer Drug Sales Market Share by Manufacturers 16
Figure 2018 Platinum based Cancer Drug Sales Market Share by Manufacturers 17
Table Global Platinum based Cancer Drug Revenue (M USD) by Manufacturers (2017-2018) 17
Table Global Platinum based Cancer Drug Revenue Share by Manufacturers (2017-2018) 18
Figure 2017 Global Platinum based Cancer Drug Revenue Share by Manufacturers 19
Figure 2018 Global Platinum based Cancer Drug Revenue Share by Manufacturers 20
Table Global Market Platinum based Cancer Drug Average Price (USD/Unit) of Key Manufacturers (2017-2018) 20
Figure Global Market Platinum based Cancer Drug Average Price (USD/Unit) of Key Manufacturers in 2017 21
Table Manufacturers Platinum based Cancer Drug Headquarters and Established 22
Figure 2017 Platinum based Cancer Drug Revenue Market Share by Manufacturers 23
Figure 2017 Platinum based Cancer Drug Revenue Market Share of Top 3 Manufacturers 24
Figure 2017 Platinum based Cancer Drug Revenue Market Share of Top 5 Manufacturers 25
Table Global Platinum based Cancer Drug Sales (K Unit) by Regions (2013-2018) 30
Table Global Platinum based Cancer Drug Sales Market Share by Regions (2013-2018) 30
Figure Global Platinum based Cancer Drug Sales Market Share by Regions (2013-2018) 31
Figure 2017 Global Platinum based Cancer Drug Sales Market Share by Regions 31
Table Global Platinum based Cancer Drug Revenue (M USD) by Regions (2013-2018) 32
Table Global Platinum based Cancer Drug Revenue Market Share by Regions (2013-2018) 32
Figure Global Platinum based Cancer Drug Revenue Market Share by Regions (2013-2018) 33
Figure 2017 Global Platinum based Cancer Drug Revenue Market Share by Regions 34
Figure Global Platinum based Cancer Drug Sales (K Unit) and Growth Rate (2013-2018) 35
Table Global Platinum based Cancer Drug Sales (K Unit), Revenue (M USD), Price (USD/Unit) (2013-2018) 35
Figure North America Platinum based Cancer Drug Sales (K Unit) and Growth Rate (2013-2018) 36
Table North America Platinum based Cancer Drug Sales (K Unit), Revenue (M USD), Price (USD/Unit) (2013-2018) 36
Figure Europe Platinum based Cancer Drug Sales (K Unit) and Growth Rate (2013-2018) 37
Table Europe Platinum based Cancer Drug Sales (K Unit), Revenue (M USD), Price (USD/Unit) (2013-2018) 38
Figure Asia-Pacific Platinum based Cancer Drug Sales (K Unit) and Growth Rate (2013-2018) 39
Table Asia-Pacific Platinum based Cancer Drug Sales (K Unit), Revenue (M USD), Price (USD/Unit) (2013-2018) 39
Figure South America Platinum based Cancer Drug Sales (K Unit) and Growth Rate (2013-2018) 40
Table South America Platinum based Cancer Drug Sales (K Unit), Revenue (M USD), Price (USD/Unit) (2013-2018) 41
Figure Middle East & Africa Platinum based Cancer Drug Sales (K Unit) and Growth Rate (2013-2018) 42
Table Middle East & Africa Platinum based Cancer Drug Sales (K Unit), Revenue (M USD), Price (USD/Unit) (2013-2018) 43
Table Global Platinum based Cancer Drug Sales (K Unit) by Types (2013-2018) 44
Table Global Platinum based Cancer Drug Sales Market Share by Types (2013-2018) 44
Figure Sales Market Share of Platinum based Cancer Drug by Types (2013-2018) 45
Figure 2017 Sales Market Share of Platinum based Cancer Drug by Types 45
Table Global Platinum based Cancer Drug Revenue (M USD) by Types (2013-2018) 46
Table Global Platinum based Cancer Drug Revenue Share by Types (2013-2018) 46
Figure Revenue Share of Platinum based Cancer Drug by Types (2013-2018) 47
Figure 2017 Revenue Market Share of Platinum based Cancer Drug by Types 47
Table Global Platinum based Cancer Drug Price (USD/Unit) by Types (2013-2018) 48
Figure Global Platinum based Cancer Drug Sales Growth Rate by Types (2013-2018) 48
Table Global Platinum based Cancer Drug Sales (K Unit) by Applications (2013-2018) 49
Table Global Platinum based Cancer Drug Sales Market Share by Applications (2013-2018) 49
Figure Global Platinum based Cancer Drug Sales Market Share by Applications (2013-2018) 50
Figure Global Platinum based Cancer Drug Sales Market Share by Applications in 2017 50
Figure Global Platinum based Cancer Drug Sales Growth Rate by Applications (2013-2018) 51
Table Sanofi Company Profile 52
Figure Platinum based Cancer Drug Product Picture of Sanofi 53
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Sanofi 2017-2018 54
Table Hengrui Medicine Company Profile 54
Figure Platinum based Cancer Drug Product Picture of Hengrui Medicine 55
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Hengrui Medicine 2017-2018 56
Table ASK Pharma Company Profile 56
Figure Platinum based Cancer Drug Product Picture of ASK Pharma 57
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of ASK Pharma 2017-2018 57
Table Yi Bai Pharmaceutical Company Profile 58
Figure Platinum based Cancer Drug Product Picture of Yi Bai Pharmaceutical 59
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Yi Bai Pharmaceutical 2017-2018 59
Table Qilu Pharmaceutical Company Profile 60
Figure Platinum based Cancer Drug Product Picture of Qilu Pharmaceutical 61
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Qilu Pharmaceutical 2017-2018 61
Table Teva Company Profile 61
Figure Platinum based Cancer Drug Product Picture of Teva 63
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Teva 2017-2018 63
Table Pfizer Company Profile 64
Figure Platinum based Cancer Drug Product Picture of Pfizer 65
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2017-2018 65
Table Dr Reddy’s Laboratories Company Profile 66
Figure Platinum based Cancer Drug Product Picture of Dr Reddy’s Laboratories 67
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Dr Reddy’s Laboratories 2017-2018 67
Table Mylan Company Profile 68
Figure Platinum based Cancer Drug Product Picture of Mylan 69
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Mylan 2017-2018 69
Table Sun Pharma Company Profile 70
Figure Platinum based Cancer Drug Product Picture of Sun Pharma 71
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Sun Pharma 2017-2018 71
Table Novartis Company Profile 72
Figure Platinum based Cancer Drug Product Picture of Novartis 73
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Novartis 2017-2018 73
Table Debiopharm Company Profile 74
Figure Platinum based Cancer Drug Product Picture of Debiopharm 75
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Debiopharm 2017-2018 75
Table Accord Healthcare Company Profile 76
Figure Platinum based Cancer Drug Product Picture of Accord Healthcare 77
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Accord Healthcare 2017-2018 77
Table SK Chemicals Company Profile 78
Figure Platinum based Cancer Drug Product Picture of SK Chemicals 79
Table Platinum based Cancer Drug Sales (K Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of SK Chemicals 2017-2018 79
Figure typical phases from research to the market for a drug candidate 81
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Biopharmaceutical Compound 82
Table Capitalized Preclinical and Clinical Period costs per Investigational Biopharmaceutical Compound 83
Figure Manufacturing Cost Structure of Platinum based Cancer Drug 83
Figure USA Labor Cost Analysis 2013-2018 84
Figure Cost of Employing a Factory Worker 85
Figure 2016 Estimated Labour Costs for the Whole Economy in Europe 86
Figure Monthly Minimum Wages in Asia 2016 87
Figure China Labor Costs 2013-2016 87
Table Average Price of Electricity to Ultimate Customers 2007-2016 88
Figure Electricity Prices for Household Consumers in 2016 89
Figure Summary of the Driving Assumptions 91
Figure Industrial Electric Rates 2016 (PER KWH) 91
Figure Manufacturing Process Analysis of Platinum based Cancer Drug 93
Figure Platinum based Cancer Drug Industrial Chain Analysis 94
Table Major Buyers of Platinum based Cancer Drug 95
Figure Marketing Channel for Biopharmaceuticals 98
Figure Conceptual Model of the Flow of Products, Services and Funds for Non-specialty Drugs Coveredunder Private Insurance and Purchased in a Retail Setting 99
Figure Marketing Channel for Biopharmaceuticals 100
Figure Flow of US Prescription Sales Contribution by Channel 101
Figure Setting Pricing Policy 102
Table Distributors/Traders List 104
Figure New Active Substance Launches 2011-2015 by Indication 107
Figure Immuno-Oncology PD-1 Inhibitor Uptake in the U.S. 108
Figure Growth of the Late Phase Oncology Pipeline, 2005-2015 109
Figure Key In-Market and Investigational Agents for NSCLC 110
Figure Key In-Market and Investigational Agents for Melanoma 110
Figure the Global Late Phase Oncology Pipeline in 2015 111
Figure Companies with Active Late Phase Oncology Pipelines 112
Figure Cancer Incidence by Country in 2014 114
Figure Cancer Mortality by Country in 2014 114
Figure USA numbers of new cancer cases for 2015 115
Figure Global GDP Growth Rate for 2016 116
Figure Real GDP Growth 2016-2020 annual Average 117
Figure USA GDP 2008-2016 (Billion USD) 118
Figure USA GDP Growth Rate Change 2015-2018 118
Figure EU GDP 2008-2016 (Billion USD) 119
Figure EU GDP Growth Rate Change 2015-2018 119
Figure Germany GDP 2008-2016 (Billion USD) 120
Figure Germany GDP Growth Rate 2015-2018 120
Figure UK GDP 2008-2016 (Billion USD) 120
Figure UK GDP Growth Rate 2015-2018 121
Figure Italy GDP 2008-2016 (Billion USD) 121
Figure Italy GDP Growth Rate 2015-2018 121
Figure France GDP 2008-2016 (Billion USD) 122
Figure France GDP Growth Rate 2015-2018 122
Figure Japan GDP 2008-2016 (Billion USD) 122
Figure Japan GDP Growth Rate 2015-2018 123
Figure China GDP 2008-2016 (Billion USD) 123
Figure China GDP Growth Rate 2015-2018 123
Figure Global Platinum based Cancer Drug Sales (K Unit) and Growth Rate Forecast (2019-2025) 124
Figure Global Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025) 125
Figure Global Platinum based Cancer Drug Price (USD/Unit) Trend Forecast (2019-2025) 126
Table Global Platinum based Cancer Drug Sales (K Unit) Forecast by Regions (2019-2025) 126
Figure Global Platinum based Cancer Drug Sales Market Share Forecast by Regions (2019-2025) 127
Figure Global Platinum based Cancer Drug Sales Market Share Forecast by Regions in 2025 127
Figure North America Platinum based Cancer Drug Sales (K Unit) and Growth Rate Forecast (2019-2025) 128
Figure North America Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025) 129
Figure Europe Platinum based Cancer Drug Sales (K Unit) and Growth Rate Forecast (2019-2025) 130
Figure Europe Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025) 131
Figure Asia-Pacific Platinum based Cancer Drug Sales (K Unit) and Growth Rate Forecast (2019-2025) 132
Figure Asia-Pacific Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025) 133
Figure South America Platinum based Cancer Drug Sales (K Unit) and Growth Rate Forecast (2019-2025) 134
Figure South America Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025) 135
Figure Middle East & Africa Platinum based Cancer Drug Sales (K Unit) and Growth Rate Forecast (2019-2025) 136
Figure Middle East & Africa Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025) 137
Table Global Platinum based Cancer Drug Revenue (M USD) Forecast by Regions (2019-2025) 137
Figure Global Platinum based Cancer Drug Revenue Market Share Forecast by Regions (2019-2025) 138
Figure Global Platinum based Cancer Drug Revenue Market Share Forecast by Regions in 2025 138
Figure North America Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025) 139
Figure Europe Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025) 140
Figure Asia-Pacific Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025) 141
Figure South America Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025) 142
Figure Middle East & Africa Platinum based Cancer Drug Revenue (M USD) and Growth Rate Forecast (2019-2025) 143
Table Global Platinum based Cancer Drug Sales (K Unit) Forecast by Types (2019-2025) 143
Table Global Platinum based Cancer Drug Sales Market Share Forecast by Types (2019-2025) 144
Figure Global Platinum based Cancer Drug Sales Market Share Forecast by Types (2019-2025) 144
Figure Global Platinum based Cancer Drug Sales Market Share Forecast by Types in 2025 145
Table Global Platinum based Cancer Drug Revenue (M USD) Forecast by Types (2019-2025) 145
Table Global Platinum based Cancer Drug Revenue Market Share Forecast by Types (2019-2025) 145
Figure Global Platinum based Cancer Drug Revenue Market Share Forecast by Types (2019-2025) 146
Figure Global Platinum based Cancer Drug Revenue Market Share Forecast by Types in 2025 147
Table Global Platinum based Cancer Drug Price (USD/Unit) Forecast by Types (2019-2025) 147
Table Global Platinum based Cancer Drug Sales (K Unit) Forecast by Application (2019-2025) 148
Table Global Platinum based Cancer Drug Sales Market Share Forecast by Application (2019-2025) 148
Figure Global Platinum based Cancer Drug Sales Market Share Forecast by Application (2019-2025) 149
Figure Global Platinum based Cancer Drug Sales Market Share Forecast by Application in 2025 149

Published By : QY Research